Nanog, a core pluripotency factor in the inner cell mass of blastocysts, is also expressed in unipotent primordial germ cells (PGCs) Transcription factors and epigenetic changes confer competence for somatic and PGC fates when naive pluripotent inner cell mass (ICM) from embryonic day (E)3.5-4.5 blastocysts develop to primed epiblast at ~E6.0 (ref. 11). Similarly, naive pluripotent ES cells in 2i medium acquire competency within ~48 h after culture in bFGF and activin A in vitro, when day-2 EpiLCs differentiate into PGCLCs in response to BMP4 (ref. 5). These putative PGCLCs show expression of ∆PE-Oct3/4-GFP (hereafter termed GOF-GFP) and Prdm1-GFP reporters (Fig. 1a and Extended Data Fig. 1a-c) after upregulation of the three key regulators of PGCLCs: Prdm1 (encoding BLIMP1), Prdm14, and Tfap2c (encoding AP-2γ) 5, 7, 8 
Nanog, a core pluripotency factor in the inner cell mass of blastocysts, is also expressed in unipotent primordial germ cells (PGCs) in mice 1 , where its precise role is yet unclear 2-4 . We investigated this in an in vitro model, in which naive pluripotent embryonic stem (ES) cells cultured in basic fibroblast growth factor (bFGF) and activin A develop as epiblast-like cells (EpiLCs) and gain competence for a PGC-like fate 5 . Consequently, bone morphogenetic protein 4 (BMP4), or ectopic expression of key germline transcription factors Prdm1, Prdm14 and Tfap2c, directly induce PGC-like cells (PGCLCs) in EpiLCs, but not in ES cells [6] [7] [8] .
Here we report an unexpected discovery that Nanog alone can induce PGCLCs in EpiLCs, independently of BMP4. We propose that after the dissolution of the naive ES-cell pluripotency network during establishment of EpiLCs 9, 10 , the epigenome is reset for cell fate determination. Indeed, we found genome-wide changes in NANOG-binding patterns between ES cells and EpiLCs, indicating epigenetic resetting of regulatory elements. Accordingly, we show that NANOG can bind and activate enhancers of Prdm1 and Prdm14 in EpiLCs in vitro; BLIMP1 (encoded by Prdm1) then directly induces Tfap2c. Furthermore, while SOX2 and NANOG promote the pluripotent state in ES cells, they show contrasting roles in EpiLCs, as Sox2 specifically represses PGCLC induction by Nanog. This study demonstrates a broadly applicable mechanistic principle for how cells acquire competence for cell fate determination, resulting in the context-dependent roles of key transcription factors during development.
Transcription factors and epigenetic changes confer competence for somatic and PGC fates when naive pluripotent inner cell mass (ICM) from embryonic day (E)3.5-4.5 blastocysts develop to primed epiblast at ~E6.0 (ref. 11) . Similarly, naive pluripotent ES cells in 2i medium acquire competency within ~48 h after culture in bFGF and activin A in vitro, when day-2 EpiLCs differentiate into PGCLCs in response to BMP4 (ref. 5) . These putative PGCLCs show expression of ∆PE-Oct3/4-GFP (hereafter termed GOF-GFP) and Prdm1-GFP reporters ( Fig. 1a and Extended Data Fig. 1a-c) after upregulation of the three key regulators of PGCLCs: Prdm1 (encoding BLIMP1), Prdm14, and Tfap2c (encoding AP-2γ) 5, 7, 8 . NANOG and PRDM14 share similar binding profiles in ES cells and contribute to pluripotency 12 . While Prdm14 is also a key regulator of PGC fate 13, 14 , the role of Nanog is unclear, although Nanog is detected in E6.5 posterior proximal epiblast 15, 16 , the site of PGC induction, and thereafter in the early germ line 1, 7 . However, we unexpectedly found that doxycycline (Dox) induced expression of Nanog alone stimulated GOF-GFP and Prdm1-GFP expression in day-2 EpiLCs, indicating specification of putative PGCLCs (Fig. 1a and Extended Data Figs 1a, d-f, 2a-e). Furthermore, Nanog apparently acts synergistically with BMP4 to increase the number of GFP + cells, which we did not see with Oct3/4 (Extended Data Fig. 2f-h ). Nanog induced PGCLCs in the presence of noggin, a BMP signalling inhibitor, demonstrating that it acts independently of BMP-SMAD signalling (Fig. 1b) . Physiological (equivalent to ES cells) or higher levels of NANOG induced PGCLCs with similar efficiency (Extended Data Fig. 3a-c) .
We analysed Nanog-induced GFP + cells, sorted by fluorescenceactivated cell sorting (FACS), which showed upregulation of the key PGC regulators, Prdm1, Prdm14 and Tfap2c, as well as Nanos3 and Dppa3, but downregulation of ES-cell-specific Klf4 ( Fig. 1c and Extended Data Fig. 3d-f ). This mirrors the response seen with BMP4-mediated PGCLC induction 5 . Notably, principal component analysis (PCA) of global gene expression confirmed that Nanog-and BMP4-induced day-4 PGCLCs are highly similar, and closely match with the previously reported day-6 PGCLCs 5 ( Fig. 1d and Extended Data Fig. 3g-j) . Furthermore, BLIMP1, PRDM14 and AP-2γ (but not KLF4) were detected in PGCLCs by immunofluorescence ( Fig. 1e and Extended Data Fig. 4 ). Thus, Nanog clearly induces PGC-like fate in EpiLCs and not their reversion to ES cells.
The Nanog-induced PGCLCs also showed unique early germlinespecific epigenetic modifications; global enrichment of H3K27me3 and erasure of H3K9me2 ( Fig. 1e and Extended Data Fig. 4 ) 17, 18 , together with the initiation of DNA demethylation through the repression of Uhrf1, Dnmt3a and Dnmt3b ( ) unsorted cells after Nanog expression (+Dox). ∆∆C t ± s.d.; n = 4 values obtained from two technical replicates from each of two biological replicates. Two-sided/unpaired t-test: **P < 0.01; *P < 0.05. cyto, cytokines; D, day; induct., induction. b, Nanog frameshift mutant alleles. KO, knockout. c, Western blot for NANOG and α-tubulin (α-TUB) as depicted. Plus or minus Dox for 2 days; gel source data are in Supplementary Fig. 1 -+ -P a r e n t a l E S c e ll s P a r e n t a l E S c e ll s P a r e n t a l E S c e ll s P a r e n t a l E S c e ll s Letter reSeArCH Prdm1 −/− embryos in vivo 22 . Furthermore, H3S10ph and γH2A.X analysis by immunofluorescence of day-6 aggregates indicated that while cell proliferation was unaffected, the rate of apoptosis increased, presumably as the differentiated cells could not survive in the culture conditions (Extended Data Fig. 6c, d ).
To investigate PGCLC induction by Nanog further, we generated CRISPR-Cas9-mediated Nanog-knockout alleles in GOF-GFP ES cells with Dox-inducible Nanog (Fig. 2b, c) . We found a significant reduction in the induction of PGCLCs from Nanog-mutant cells in response to BMP4 (Fig. 2d-f ), but ectopic Nanog expression rescued this deficit, suggesting complementary roles for BMP4 and Nanog in PGCLC induction.
Next, we investigated whether the WNT-BRACHYURY pathway is important for PGCLC induction by Nanog, as is the case with BMP4 (ref. 24) . We induced PGCLCs in the presence of XAV939 tankyrase inhibitor, which promotes degradation of β-catenin 25 , resulting in the repression of Brachyury (Extended Data Fig. 6e-g ). PGCLC induction with BMP4 was repressed by XAV939 but not when induced with Nanog (Extended Data Fig. 6h, i) . Furthermore, WNT had no detectable effect on Nanog expression (Extended Data Fig. 6g, i) , indicating that Nanog acts independently of WNT-BRACHYURY.
We then asked at which point during the transition of ES cells to EpiLCs cells become responsive to Nanog for PGCLC induction. We found that a large majority of day-1 EpiLCs (63.8%) reverted to ES cells Fig. 7b ; gel source data are in Supplementary Fig. 1 . e, Analysis (qPCR) after Sox2 knockout (KO; +Dex) and Nanog induction (ind.; +Dox); ∆∆C t ± s.d.; n = 4 values obtained from two technical replicates from each of two biological replicates. Parental ES cells were used as a reference for P values (two-sided/unpaired t-test): **P < 0.01; *P < 0.05. Experimental design is in Extended Data Fig. 7e . f, PGCLC induction with Dox-inducible transgenes (Nanog, Sox2 or Nanog/Sox2); day-4 brightfield/GOF-GFP + cells (%) after FACS. Scale bar, 200 μm. Letter reSeArCH when transferred to 2i/LIF medium, and Nanog enhanced this response (to 84.7%), as confirmed by expression of Klf4 and repression of PGC genes ( Fig. 3a-c) . This reversion to ES cells diminished significantly in day-2 EpiLCs (28.4%), and Nanog repressed it further (to 9.8%); instead these cells exhibited a distinct phenotype with expression of Brachyury and Wnt3 mesodermal genes ( Fig. 3a-c) . Thus, day-2 EpiLCs do not revert to ES cells but acquire competence for PGCLC fate in response to Nanog.
ES cells ES cells ES cells ES cells ES cells ES cells
Nanog and Sox2 promote pluripotency in the ICM, but thereafter Nanog is detected in the E6.25 posterior epiblast, where PGCs arise 15, 16 , and Sox2 in the anterior epiblast, where it promotes neuronal fate and inhibits mesodermal specification 16 . Sox2 also represses germline genes in ES cells 26 (Extended Data Fig. 7a ). We tested the roles of Nanog and Sox2 in our experimental model using ES cells with dexamethasone (Dex)-inducible knockout of Sox2 (ref. 27) , in conjunction with Doxinducible Nanog (Fig. 3d and Extended Data Fig. 7b ). Loss of Sox2 caused a moderate upregulation of Prdm1 and Tfap2c in ES cells without affecting Nanog expression (Extended Data Fig. 7c, d ). Notably, Nanog induced Prdm1, Prdm14 and Tfap2c in Sox2-knockout day-1 EpiLCs but not in wild-type cells ( 28 . Thus, progressive downregulation of Sox2 in EpiLCs contributes to competency for PGCLCs, but thereafter Sox2 supports proliferation of early germ cells. This further confirms that NANOG and BMP-SMAD act independently during PGCLC induction.
While both Nanog and BMP4 induce PGCLCs, the temporal sequence of Prdm1, Prdm14 and Tfap2c induction differs slightly. Nanog induces Prdm14 first at 3 h, which increases rapidly over ~18 h (Fig. 4a ). This is followed by Prdm1 at ~12 h, which increases over the following 12 h, and finally Tfap2c expression at ~18 h. Thus, all the three regulators of PGCLCs are upregulated within ~24 h. While the response of day-2 EpiLCs to BMP4 is similar, Prdm1 expression is detected first and slightly ahead of Tfap2c, followed by Prdm14 (Extended Data Fig. 9a ). Tfap2c, a direct target of BLIMP1 (refs 7, 8) , is rapidly induced by Prdm1 alone within 6 h (Extended Data Fig. 9b ).
To explore how NANOG promotes both pluripotency and the induction of PGCLCs, we performed NANOG chromatin immunoprecipitation followed by sequencing (ChIP-seq) in ES cells and 3 h after induction of physiological levels (equivalent to ES cells) of NANOG in EpiLCs (Extended Data Fig. 9c ). We found NANOG binding primarily in the intergenic regions and introns (>90%), where enhancer elements reside ( Fig. 4b and Extended Data Fig. 9d) , with marked differences in binding patterns and enriched motifs in ES cells compared to EpiLCs (Fig. 4c and Extended Data Fig. 9e ); this provides a basis for the contextdependent functions of NANOG. Overall, many day-2 EpiLC enhancers bound by NANOG show enrichment of H3K27ac in day-2 PGCLCs, indicative of active enhancers 29 (Extended Data Fig. 9f-h ). This shows that during PGCLC induction, NANOG might contribute to the activation of these elements together with BLIMP1, PRDM14 and AP-2γ. Importantly, we also found and confirmed intergenic NANOGbinding sites proximate to the Prdm14 and Prdm1 loci ( Fig. 4d and Extended Data Fig. 10a, b) . These sites were devoid of the promoterand gene-body-associated H3K4me3 and H3K36me3 modifications, respectively. Instead, they were enriched for the enhancer-associated H3K4me1 modification in EpiLCs, suggesting their priming before activation via NANOG and gain of H3K27ac in PGCLCs (Fig. 4d and Extended Data Fig. 10a ). Since Prdm14 is critical for both ES cells and PGCLCs, its enhancer showed a similar H3K4me1/H3K27ac/NANOG enrichment profile in both cell types. and Tfap2c by Nanog (+Dox) in EpiLCs; ∆∆C t ± s.d.; n = 6 values obtained from three technical replicates from each of two biological replicates. b, Genomewide NANOG binding in day-2 EpiLCs 3 h after Nanog (+Dox). 'Distal' intergenic peaks are ± 50 kb away from coding genes, and those further away are designated as 'intergenic' . c, NANOG ChIP-seq in ES cells and day-1/2 EpiLCs, with specific or shared high-confidence peaks; n = 2 biological replicates. D, day. d, ChIP-seq tracks 9, 30 at Prdm1 and Prdm14 loci, with putative enhancers (boxed) analysed in e-g. RPM, reads per million. e, Analysis of Prdm1 enhancer-luciferase reporter in ES cells, EpiLCs, and after PGCLC induction (+Dox, EpiLC aggregations (aggr), unsorted). Mean luciferase activity normalized to protein quantity (luc/pro) ± s.d.; n = 3 technical replicates. Reference for P value (two-sided/unpaired t-test): EpiLC aggregations minus Dox; **P < 0.01; *P < 0.05. Controls and replicates are in Extended Data Fig. 10c , e. f, SOX2 ChIP-qPCR in ES cells and 6 h after PGCLC induction plus or minus Dox (+/−Sox2) (unsorted EpiLC aggregations). Mean of fold enrichment over negative region ± standard error of the mean; n = 4 values obtained from two technical replicates from each of two biological replicates. Reference for P values (two-sided/unpaired t-test): IgG; *P < 0.05. enh, enhancer; Neg., negative. g, Analysis of Prdm14 enhancer-luciferase reporter in ES cells, EpiLCs and after PGCLC induction (+Dox, EpiLC aggregations, unsorted). Mean luciferase activity normalized to protein quantity ± s.d.; n = 3 technical replicates. Reference for P values (two-sided/unpaired t-test): EpiLC aggregations minus Dox 24 h; **P < 0.01. Colour code is as in e; controls and replicates are in Extended Data Fig. 10c , e. Letter reSeArCH
Next, we tested the putative Prdm1 enhancer in a luciferase reporter assay, and found that following its low activity in ES cells and EpiLCs, Nanog activated the enhancer within 24 h after PGCLC induction ( Fig. 4e and Extended Data Fig. 10c, d) . Notably, Sox2 strongly repressed this activity, consistent with SOX2 binding to this enhancer (Fig. 4e, f and Extended Data Fig. 10c, d ). By contrast, the putative Prdm14 enhancer, which did not bind SOX2 (Fig. 4f) , was active in ES cells; this declined in EpiLCs but increased again within 12 h after the induction of PGCLCs by Nanog (Fig. 4g and Extended Data Fig. 10c, e) . This reflects the importance of Prdm14 for both pluripotency and PGCLC fate [12] [13] [14] . Notably, while both BRACHYURY and NANOG bind to and activate the Prdm1 enhancer 24 , NANOG acts independently of WNT during PGCLC induction (Fig. 4e and Extended Data  Figs 6e-i, 10c, d) . Thus, NANOG activates key regulators of PGCLCs independently of BMP4 and WNT signalling. Additional regulatory elements associated with Prdm1 and Prdm14 may respond similarly.
The resetting of the epigenome during the gain of competency for PGC-like fate is reflected in the differential NANOG-binding pattern in ES cells and EpiLCs, consistent with the role of NANOG in pluripotency and PGCLC specification (Extended Data Fig. 10f) . Nanog is detected in the proximal epiblast and the early germ line 15, 16 . Transcription factors also affect competency, since SOX2 inhibits the induction of PGCLCs by NANOG, while NANOG and SOX2 cooperatively promote pluripotency in the ICM/ES cells. NANOG acts independently of BMP4 during PGCLC induction, but they might act cooperatively in vivo, since loss of Nanog markedly impairs the efficiency of PGCLC specification via BMP4. Notably, epigenome resetting during differentiation of competent EpiLCs establishes a mechanistic paradigm for context-dependent roles of transcription factors such as NANOG that could apply generally during development.
Online Content Methods, along with any additional Extended Data display items and Source Data, are available in the online version of the paper; references unique to these sections appear only in the online paper. ; R&D) was added to the media at day 0 of PGCLC induction. For inhibition of WNT signalling, XAV939 (1 μM; Sigma-Aldrich) was added to the media.
Reversion of epiblast-like cells into ES-like cells.
Day-1 or day-2 EpiLCs were transferred into GMEM 15%KSR 2i/LIF with or without Dox in monolayer culture. In addition, day-1 or day-2 EpiLCs were aggregated in low-cell-binding U-bottom-shaped 96-well plates (Thermo Scientific) (1,000-2,000 cells per well) in PGCLC induction media (GMEM with l-glutamine (Life Technologies), 15% KSR (Life Technologies), 1× MEM NEAA (Life Technologies), 1× sodium pyruvate (Life Technologies), 1× 2-mercaptoethanol (Life Technologies), 1× penicillin/ streptomycin (Life Technologies)) and Dox. The medium was replaced daily. After 3 days, the GFP reporter signal was analysed with a fluorescence microscope and via FACS analysis. RNA was collected from pooled cells for qRT-PCR. EGCLC derivation. Day-4 aggregates were dissociated with TrypLE and plated on mitomycin C-treated mouse embryonic fibroblast (MEF) feeder cells with PGC selection medium (DMEM with l-glutamine (Life Technologies), 15% fetal bovine serum (FBS; Sigma-Aldrich)), LIF, 15 ng ml −1 bFGF, 30 ng ml −1 SCF (R&D) and 2 μM all trans-retinoic acid (Sigma-Aldrich). Retinoic acid promotes germ cell self-renewal while promoting differentiation of ES cells 20, 21 . The media was replaced daily. After 5 days, proliferating GFP + cells were dissociated with TrypLE and plated on fibronectin-coated dishes with ESC medium (N2B27 with 2i/LIF). FACS. PGCLCs were dissociated with TrypLE, washed with DMEM containing 10% FBS and resuspended with 1×PBS containing 0.1% BSA. Large clumps of cells were removed using a cell strainer (BD Biosciences). The cells were analysed and sorted on flow cytometers (FACS Calibur, BD Biosciences; MoFlo high speed cell sorter, Beckman Coulter; S3 cell sorter, Biorad). RT-qPCR. Total RNAs from ES cells, EpiLCs and FACS-sorted cells were extracted using the RNeasy Mini Kit (Qiagen) or Picopure RNA Isolation Kit (Life Technologies). The total RNAs were reverse transcribed by the Quantitect Reverse Transcription Kit (QIAGEN). The first-strand cDNAs were used for RT-qPCR analysis with SYBR Green PCR reagent (Sigma-Aldrich). The primer sequences used for the qRT-PCR are listed in Supplementary Table 1. Student's t-test was used to test for significance. Microarray. ES cells and day-4 PGCLCs were dissociated and sorted with a MoFlo high-speed cell sorter (Beckman Coulter). Total RNAs were extracted using the RNeasy Mini Kit (QIAGEN). Complementary RNA (cRNA) generation, quality control, hybridization and data analysis were performed by Cambridge Genomic Services at the University of Cambridge. Raw intensity values from Illumina MouseWG-6 v.2.0 expression beadchip microarrays were pre-processed with the Bioconductor lumi and preprocessCore packages (http://www.bioconductor.org): Probes that were not detected in at least one sample were removed, Variance stabilization transformation (VST) was applied, and samples were quantile-normalized. Differential expression was evaluated with the Bioconductor limma package. Fig. 3j ). Our data set was assayed on an Illumina MouseWG-6 v.2.0 expression beadchip, the data set from ref. 5 was assayed on the Affymetrix Mouse Genome 430 2.0 Array platform. We therefore quantile-normalized the data sets to ensure that the data sets span comparable ranges of expression values. PCA was performed on the centre-scaled expression values, where systematic differences between platforms are mainly captured by the first principal component. Immunofluorescence stainings. Day-3, day-4 and day-6 aggregates were fixed with 2% or 4% paraformaldehyde for 20 min at room temperature or for 2 h at 4 °C. Fixed aggregates were washed several times in PBS and transferred into 10% sucrose/PBS (2 h), 20% sucrose/PBS (2 h) and finally into OCT embedding matrix (overnight; CellPath). Next day, cell aggregates were embedded in OCT in tissue moulds and stored at −80 °C. A Leica Cryostat CM3050S was used to cut the OCT blocks in 6-8-μm-thick sections, which were collected on SuperFrost Plus slides (VWR).
Comparison with published microarray data (Extended Data
For immunofluorescence staining, the slides were washed with PBS, permeabilized with PBS/0.1-1% Triton X-100 and then incubated with primary antibodies in permeabilization buffer including 5% donkey serum (Sigma-Aldrich) overnight at 4 °C. Next day, slides were washed with PBS and incubated with secondary antibodies in permeabilization buffer for 2 h at room temperature, washed with PBS, incubated with 4′,6-diamidino-2-phenylindole (DAPI) in PBS for 15-30 min, and mounted using Vectashield Mounting Medium (VECTOR Labs). Images were acquired using a Leica SP5 or SP8 confocal microscope. For 5hmC stainings, it was required to perform an additional antigen retrieval step before incubation with primary antibodies: slides with sections were transferred into TE buffer, pH 8, at ~95 °C and microwaved at very low power for 45 min.
The following primary antibodies were used: mouse anti-OCT3/4 (1:100, BD Biosciences, O50808), rat anti-BLIMP1 (1:50, eBioscience, clone 6D3, 14-5963), rabbit anti-AP-2γ (1:250, SantaCruz, sc-8977), rabbit anti-PRDM14 (1:250, a gift from D. Reinberg), rabbit anti-DAZL (1:500, Abcam, ab34139), mouse antiH3K9me2 (1:250, Abcam, ab1220 and 1:500, Millipore, 07-441), rabbit antiH3K27me3 (1:500, Millipore, 07-449), rabbit anti-TET1 (1:500, Millipore, 09-872), rabbit anti-5hmC (1:500, Active Motif, 39791), goat anti-KLF4 (1:100, R&D, AF3158), rabbit anti-H3S10ph (1:500, Millipore, 06-5770), mouse anti-γH2A.X (1:250, Millipore, 05-636), rat anti-GFP (1:500, Nakalai Tesque, GF090R). Alexa Fluor488 and 568 were used as secondary antibodies (1:500, Life Technologies). Quantification of immunofluorescence data. All quantifications were preformed using Fiji
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. The DAPI, H3S10ph and γH2A.X channels were processed by applying a Gaussian Blur (H3S10ph staining: DAPI/H3S10ph: σ 0.5/1.1; DAPI/ γH2A.X: σ 1.0/1.5) to reduce noise. The images were then binarized using the Otsu thresholding algorithm and holes were filled before the total signal area was measured. In day-6 Prdm1 −/− plus Dox aggregates, many cells underwent cell death. Therefore, nuclei with bright discrete spots of DAPI signal, which indicates chromatin condensation, were excluded from the analysis. The diameter of ~10 cells was measured and used to calculate the average area of one cell to estimate the number of cells in the field of view (DAPI + area/area of one cell). For all other quantifications on a single-cell level, we developed 'Object Scan' , which is an object mapping and analysis plugin for Fiji that combines advanced functions with a user-friendly interface. Images are processed with a choice of feature enhancement algorithms, objects are identified by patch sampling to detect intensity edges based on the local energy gradient, and the generated twodimensional masks are clustered in three dimensions to define the final object map for analysis. We used Object Scan to carry out DoG processing and contained signal analysis using the DAPI channel for object mapping, watershed segmentation, a scan radius of one and the following channel specific settings: edge gradient = 10, estimated object radius = 9 μm. The results were scale normalized (X − X min /X max − X min ) to the range 0 to 1 for comparison. Student's t-test was used to test for significance. The Object Scan plugin is available from this link: http://www.gurdon.cam.ac.uk/stafflinks/downloadspublic/imaging-plugins. ChIP. Low cell number ChIP-qPCR was performed as previously described 35 . 3 × 10 5 cells per ChIP were fixed in 1% formaldehyde (room temperature, 10 min), quenched with 1 vol. of 250 mM glycine (room temperature, 5 min), and rinsed with chilled TBSE buffer (20 mM Tris-HCl, 150 mM NaCl, 1 mM EDTA) twice before storage at −80 °C. After thawing the cells on ice, fixed cells were lysed with 100 μl 1% SDS lysis buffer (50 mM Tris-HCl pH 8, 10 mM EDTA, 1% SDS, Roche protease inhibitor cocktail; on ice, 5 min) and then centrifuged (2,000 r.p.m., 10 min). Pellet was resuspended in 100 μl of dilution buffer (16.7 mM Tris-HCl, pH 8, 167 mM NaCl, 1.2 mM EDTA, 1.1% Triton X-100, 0.01% SDS, Roche protease inhibitor cocktail). Samples were sonicated nine times (30-s pulses with 30-s break interval) using the Bioruptor water bath sonicator (Diagenode). Chromatin extracts were then precleared with Dynal Magnetic Beads (Invitrogen) (4 °C, 1 h) followed by centrifugation (2,000 r.p.m., 30 min). Supernatant (precleared chromatin) was immunoprecipitated overnight with Dynal Magnetic Beads coupled with anti-NANOG antibody (1 μg per ChIP, Cosmo Bio Co., RCAB0001P) or normal rabbit serum (1 μg per ChIP). On the next day, beads were washed (nutate in wash buffer for 5 min at 4 °C) in low-salt buffer (0.1% SDS, 1% Triton X-100, 2 mM EDTA, 20 mM Tris-HCl, pH 8.0, 150 mM NaCl), high-salt buffer (0.1% SDS, 1% Triton X-100, 2 mM EDTA, 20 mM Tris-HCl, pH 8.0, 300 mM NaCl) and LiCl buffer (0.25 M LiCl, 1% NP400, 1% Na deoxycholate, 1 mM EDTA, 10 mM Tris-HCl, pH 8.0), for a total of three washes. Following an additional wash in TE, elution was performed in a PCR machine (68 °C, 10 min). After digesting and reverse crosslinking (with Proteinase K at 42 °C for 2 h and 68 °C for 6 h) DNA was purified (phenol-chloroform extraction) and used for qPCR analysis. For the negative control region, we used the Snai3 locus as described previously 36 . Student's t-test was used to test for significance.
The same protocol was used for the SOX2 ChIP with some deviations. Day-2 EpiLCs were aggregated in low-binding plates for 6 h in the presence of 200 ng ml
of Dox before collection. 5 × 10 6 ES cells and EpiLCs, respectively, were fixed and processed as described earlier. Samples were sonicated 20 times (30-s pulses with 30-s break interval) using a Bioruptor water bath sonicator (Diagenode). Samples were divided for immunoprecipitations with SOX2 antibody (10 μg per ChIP, Santa Cruz, sc-17320 X) or normal rabbit IgG (10 μg per ChIP, Santa Cruz, sc-2027 X) as a negative control. Beads were washed with low-salt buffer, and twice with high-salt buffer for 10 min each. The beads were rinsed in TE, resuspended in Proteinase K digestion buffer (20 mM HEPES, 1 mM EDTA, 0.5% SDS) with 2 μl of 10 mg ml −1 Proteinase K and incubated for 15 min at 50 °C. In parallel, 2 μl of 10 mg ml −1 Proteinase K was added to the saved input samples. Three microlitres 5 M NaCl was added to the supernatants and the input samples. To reverse the crosslinks, samples were incubated at 42 °C for 2 h and 68 °C overnight. Next day, the DNA was purified using Agencourt Ampure XP beads (Beckman Coulter) according to the manufacturer's instructions. The purified DNA was used for qPCR analysis. For the negative control region, we used the Snai3 locus. Student's t-test was used to test for significance. The primer sequences used for RT-qPCRs are listed in Supplementary Table 1 . NANOG ChIP-seq. The NANOG ChIP for subsequent sequencing was performed as described earlier with some deviations. Day-1 or day-2 EpiLCs were aggregated in low-binding plates for 3 h in the presence of 200 ng ml −1 of Dox. ES cells and EpiLCs were fixed and processed as described earlier. 3 × 10 6 fixed cells were lysed with 1 ml 1% SDS lysis buffer and then centrifuged (2,000 r.p.m., 15 min). Nuclear fraction was resuspended in 0.9 ml of dilution buffer. Samples were sonicated ten times (30-s pulses with 30-s break interval) using a Bioruptor water bath sonicator (Diagenode). Immunoprecipitations were performed with anti-NANOG antibody (2 μg per ChIP, Cosmo Bio Co., RCAB0001P). After elution, samples were digested with Proteinase K and reverse crosslinked for 6 h at 68 °C. Twelve nanograms of purified DNA was used for library preparation using Ovation Ultralow DR Multiplex System (Nugen). Once prepared, library was size selected and sequenced using HiSeq2000 with single-end 50 nucleotides read length. ChIP-seq analysis. ChIP-seq reads were aligned with the bwa aligner (http:// bio-bwa.sourceforge.net) to the mouse reference genome (GRCm38/mm10). Peaks were called with MACS (version 2.1.0; https://github.com/taoliu/MACS) and visualized using the Integrative Genomics Viewer (https://www.broadinstitute.org/ igv/). Peak regions from two biological replicates were intersected using bedops (http://bedops.readthedocs.org). Overlapping peak regions with peak summits within <50 nucleotides distance in both replicates were retained. Peak regions from the three cell types were merged. Differences in ChIP-seq read intensities on peak regions were evaluated by using diffReps (http://code.google.com/p/ diffreps) and MACS (macs2 bdgdiff). High-confidence sets of differentially bound regions that were detected by both methods were selected for further analysis by applying the following thresholds for diffReps: pValue <0.001 and abs(log2FC) > 1. Previously published H3K27ac ChIP-seq data sets 9, 30 were aligned to the mouse reference genome in a similar manner as described earlier, and H3K27ac enrichment (log(ChIP/input) values were determined on NANOG peak regions. De novo motif analysis. High-confidence MACS peaks, for which the distance of the peak summits in both replicates was <50 nucleotides, were selected. De novo motifs were determined with HOMER (http://homer.salk.edu/homer) in the 2,000 top-enriched peaks in ES cells, day-1 and day-2 EpiLCs for both repeat-masked and repeat-unmasked regions within ± 50 nucleotides of the peak summit. Luciferase assay. Genomic regions containing putative enhancers of Prdm1 and Prdm14, as well as a negative control region depleted of enhancer signatures, were amplified from mouse E14 ES-cell genomic DNA. These regions were cloned into a PiggyBAC-based firefly luciferase reporter plasmid upstream of a minimal TK promoter. Stable luciferase reporter GOF-GFP ES cell lines, which can overexpress Nanog, Nanog/Sox2 or Brachyury upon Dox addition, were established. Cell pellets were collected from ES cells cultured in N2B27 2i/LIF, day-2 EpiLCs and EpiLCs after PGCLC induction ±Dox at 12/24 h. Luciferase assays were performed with the ONE-Glo Luciferase Assay System (Promega). Protein concentration in each lysate was quantified by Pierce 660 nm Protein Assay (Thermo Scientific). Relative luciferase activities were obtained by dividing luciferase activity by protein concentration in each sample. Blastocyst injections. ES-cell clones carrying both the Nanog transgene and a CAG monomeric Kusabira-orange (mKO) fluorescence reporter were selected by neomycin (Sigma-Aldrich) and zeocine (Life Technologies). Day-4 PGCLCs were induced from day-2 EpiLCs with Nanog and used for derivation of EGCLCs. For ES cells or day-4 PGCLC injections, GOF-GFP ES cells were co-transfected with a vector, which enabled inducible expression of Nanog and constitutive expression of Venus, a variant of eGFP. For day-4 PGCLCs, after induction of PGCLCs with Nanog, cells were stained with PE-conjugated-CD61 antibody (1:10, Biolegend, 104308) and Alexa660-conjugated-SSEA-1 antibody (2.5 μl per 105 cells, eBioscience, clone eBioMC-480, 50-8813) according to the manufacturer's instructions. Double-positive PGCLC cells were collected by using a S3 cell sorter (Biorad). Embryos for chimaera experiments were obtained from CBA/ C57BL/6 F1 crossed with C57BL/6 mice. Blind tests or randomization methods were not used. The sex of embryos was not determined. Manipulations of embryos were performed as described previously 37 . Briefly, five cells were injected into a morula, which were subsequently cultured in KSOM (Millipore). On the following day, the embryos were transferred into the uteri of pseudopregnant mice. All embryos were analysed 1 week after embryo transfer, which corresponded to E9.5. Generation of Nanog-knockout ES cells. The CRISPR-Cas9 system was used to generate Nanog-knockout ES cells. Guide RNAs (gRNAs) targeting exon 1 of the Nanog gene were cloned into pX330 (Addgene) 38 . One microgram of this plasmid was transfected with a pPyCAG-monomeric Kusabira Orange-IRES-Pac plasmid. Transfected cells were selected by puromycin (1 μg ml
) for 2 days. Clonal Nanog-knockout ES cell lines were established and mutations of Nanog alleles were confirmed by qPCR, western blotting and DNA sequencing. Subsequently, pPBh-CMV*1-Nanog-pA plasmid was transfected into those lines with pPyCAG-PBase and pPBhCMV*1-rtTA-IRESNeo r to generate Nanog-knockout ES cell lines carrying a Dox-inducible Nanog transgene. Loss of Nanog affected the growth of ES cells. Thus, these cell lines were maintained in N2B27 2i/LIF with a low dose of Dox (100 ng ml ). gRNA sequences are listed in Supplementary Table 1 . Western blots. 5 × 10 4 cells were lysed in lysis buffer (50 mM Tris-HCl (pH 8.0), 1% SDS, 10 mM EDTA). Protein concentration was measured by Bicinchoninic Acid Kit (Sigma-Aldrich). The protein amount was adjusted among samples, then 4 × Laemmli buffer was added. Samples were boiled at 95 °C for 5 min. Proteins were separated on 10% acrylamide gels, blotted on Immobilon-P transfer membrane (Millipore). The membrane was blocked with 5% skimmed milk and incubated with primary antibodies: anti-NANOG (1:500, mouse IgG, eBioscience, clone eBioMLC-51, 14-5761), anti-SOX2 (1:500, rabbit IgG, Cell Signaling, 2748), anti-α-tubulin (1:1,000, mouse IgG, Sigma-Aldrich, clone DM1A, T9026). Primary antibodies were detected on X-ray film with anti-rabbit or anti-mouse IgG conjugated with horseradish peroxidase (Dako) followed by detection using Western Detection System (GE Healthcare). For gel source data, see Supplementary Fig. 1 . Generation of Sox2-conditional-knockout ES cells with Dox-inducible Nanog transgene. pPBhCMV*1-Nanog-pA, pPBCAG-rtTA-IRESNeo r and pPyCAGPBase were transfected into the Sox2-conditional-knockout ES cell line (2CG2) 27 . After 1 week of neomycin selection (80 μg ml −1 ), pooled cells were used for the subsequent experiments. Dexamethasone-inducible Sox2-knockout and Dox-inducible Nanog expression were confirmed by qPCR and western blotting. Dox (for Nanog expression) with noggin from GOF-GFP EpiLCs. Representative brightfield/GFP images at day 4. GFP + cells are induced in both conditions. Scale bar, 200 μm. c, Physiological (equivalent to ES cells) or higher levels of Nanog induce PGCLCs with comparable efficiency. FACS for GFP at day 4 of PGCLC induction with 100 or 700 ng ml −1 Dox (for Nanog expression) with noggin from GOF-GFP or Prdm1-GFP EpiLCs. D, day; SSC, side scatter. d, Alternative representation of qPCR data for Nanog, Prdm1 and Tfap2c shown in Fig. 1c . The induction of these genes in plus cytokine conditions appears less evident, when compared with plus Dox conditions. The data were log 2 -scaled, which allows a better comparison. e, qPCR analysis of female GOF-GFP cells. GFP + cells were FACS-sorted. Note the upregulation of PGC markers but not of the ES-cell marker Klf4. ∆∆C t mean values ± s.d.; n = 3 biological replicates. Colour code is shown in d. Related to Fig. 1c. f, qPCR analysis Fig. 1c . g, The transcriptomes of Nanog-and cytokine-induced PGCLCs are highly similar. Scatter plot showing the correlation of microarray data of ES cells, FACS-sorted day-4 PGCLCs induced by cytokines or Nanog with noggin. R indicates the Pearson correlation coefficient. n = 2 biological replicates; related to Fig. 1d . h, Nanog-and cytokine-induced PGCLCs cluster together as shown in unsupervised hierarchical clustering of microarray data described in g. Related to Fig. 1d. i, Heat map showing the expression levels of selected genes from microarray data described in g. Related to Fig. 1d . j, Nanog-induced day-4 PGCLCs are closely related to cytokine-induced day-6 PGCLCs. PCA analysis with published microarray data sets 5 (cross-platform comparison; see Methods for details). Note that the separation of ES cell samples is probably due to differences in genomic background and culture conditions. 
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Extended Data Figure 9 | Nanog shows a cell-type-specific binding pattern and induces Prdm1, Prdm14 and Tfap2c. a, Time-course qPCR for Prdm1, Prdm14 and Tfap2c between 1-48 h after PGCLC induction with cytokines from GOF-GFP EpiLCs. ∆∆C t mean values ± s.d.; n = 3 technical replicates. Related to Fig. 4a . b, Prdm1 alone can induce the expression of Tfap2c. GOF-GFP EpiLCs with combinations of Doxinducible transgenes encoding Prdm1, Prdm14 and/or Nanog plus or minus Dox for 6 h were analysed by qPCR. The expression of Prdm1, Prdm14 and/or Nanog is upregulated in the corresponding EpiLCs upon Dox addition. ∆∆C t mean values ± s.d.; n = 4 values obtained from two technical replicates from each of two biological replicates. Two-sided/ unpaired t-test: **P < 0.01; *P < 0.05. D, day. c, To acquire sufficient numbers of cells for ChIP-seq studies, GOF-GFP day-1 or day-2 EpiLCs (~1 × 10 6 cells per 6-cm plate) with Dox-inducible Nanog transgenes were aggregated in low-binding plates plus Dox to induce PGCLCs. qPCR analysis of day-1 and day-2 EpiLCs after 3 h with 100 or 200 ng ml −1 Dox is shown. The addition of 200 ng ml −1 of Dox results in Nanog expression levels comparable to ES cells after 3 h. ∆∆C t mean values ± s.d.; n = 4 values obtained from two technical replicates from each of two biological replicates. Two-sided/unpaired t-test: **P < 0.01; NS, not significant. D, day. d, NANOG ChIP-seq analysis shows genomic distribution of NANOG in GOF-GFP ES cells and day-1 EpiLCs plus Nanog (+Dox) for 3 h. 'Distal' refers to intergenic peaks, which are within ±50 kb of an annotated coding gene, while those further away are categorized as 'intergenic' . Related to Fig. 4b. e 
